DSM Venturing

DSM Venturing is the corporate venture capital arm of Royal DSM, established in 2001 and headquartered in Heerlen, Netherlands. The firm focuses on investing in start-up companies that develop innovative products and services within the life sciences sector, which encompasses both animal and human health and nutrition. Over the years, DSM Venturing has invested in more than fifty emerging companies across the United States, Europe, and Israel. Its primary objective is to generate strategic options and enhance value for DSM and its broader ecosystem while achieving sustainable venture-grade investment returns.

Rob Beudeker

Investment Director

Scott Horner

Regional Managing Director North America

Erik Rutten

Senior Investment Manager

88 past transactions

Vivici

Series A in 2025
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.

NutriLeads

Series C in 2023
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Octarine Bio

Series A in 2023
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives, utilizing synthetic biology to create a range of natural and novel compounds. Through its biosynthetic platform, Octarine Bio focuses on producing superior cannabinoids aimed at the pharmaceutical industry, improving pharmacokinetic and therapeutic properties. Its innovative approach enables healthcare professionals to better address neurological and psychological disorders, ultimately enhancing health and well-being.

Vivici

Seed Round in 2023
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.

Meatable

Series B in 2023
Meatable is a Dutch food production company that specializes in creating cultured meat using stem cell technology. Founded in 2019, the company employs pluripotent stem cells to transform various types of cells into muscle or fat tissue, eliminating the need for animal slaughter. This process enables Meatable to produce sustainable, guilt-free meat without compromising taste and texture.

Incredo

Series C in 2023
Incredo, a global food-tech company formerly known as DouxMatok, specializes in developing innovative technologies aimed at reducing sugar consumption while maintaining the sensory qualities of sweetness. Founded in 2014 and headquartered in Petach-Tikva, Israel, Incredo has created a proprietary solution that enhances the sweetness of real cane sugar without the undesirable aftertaste, allowing for a significant reduction in sugar content in various food products. The company's approach ensures that consumers can enjoy their favorite foods and snacks with less sugar, without sacrificing taste, mouthfeel, or texture. This focus on healthier consumption aligns with growing consumer demand for nutritious alternatives in the food industry.

VitaminLab

Series A in 2023
VitaminLab develops personalized vitamin regimens by integrating an individual's health history, nutrient testing results, and health data through a proprietary matching algorithm to create personalized supplements. The company designs supplements using natural ingredients such as beetroot, stevia, and prebiotics, tailoring products to DNA, blood markers, and body type. Led by pharmacists and health care professionals, VitaminLab aims to reform the supplement industry by moving away from one-size-fits-all products toward individualized nutrition solutions.

Athian

Seed Round in 2023
Athian enables environmental sustainability in animal agriculture by aggregating, certifying, and funding greenhouse gas reduction plans. Its platform provides verified GHG credits to CPG companies, food service providers, and retailers, helping beef and dairy producers capture carbon credits earned through sustainable efforts.

Paleo

Series A in 2023
Paleo is a food ingredient company focused on plant-based foods. It develops ingredients to enhance taste, nutrition, and sustainability, enabling products that resemble real meat or seafood without animal use. The company specializes in bioscience-based ingredients, including animal-free heme proteins produced through precision fermentation. These bio-identical heme proteins are GMO-free and provide the same sensory and nutritional properties as animal-derived heme, helping brands create sustainable plant-based products that taste and feel like the real thing.

Meala Foodtech

Pre Seed Round in 2023
Meala develops clean-label texturizinng proteins enabling simpler, healthier, and more sustainable food.

Miach Orthopaedics

Series B in 2023
Miach Orthopaedics is a medical device company based in Westborough, Massachusetts, specializing in the development of bio-engineered surgical implants aimed at promoting new tissue growth and aiding in connective tissue repair. Founded in 2016, the company focuses on its innovative Bridge-Enhanced ACL Repair technology, which serves as an alternative to traditional anterior cruciate ligament (ACL) reconstruction. This technology provides surgeons with a method to restore the normal anatomy and function of the knee for patients who have experienced ACL injuries, offering a promising option for recovery and rehabilitation.

Flore by Sun Genomics

Series B in 2022
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Octarine Bio

Seed Round in 2022
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives, utilizing synthetic biology to create a range of natural and novel compounds. Through its biosynthetic platform, Octarine Bio focuses on producing superior cannabinoids aimed at the pharmaceutical industry, improving pharmacokinetic and therapeutic properties. Its innovative approach enables healthcare professionals to better address neurological and psychological disorders, ultimately enhancing health and well-being.

Momentous

Series A in 2022
Momentous is a nutritional supplement company specializing in performance products. Founded in 2016 by Matt Wan and Rob Dyrdek, the company offers innovative supplements designed by sports experts, using high-quality ingredients, free from fillers, certified safe, and gluten-free.

Rootine

Series A in 2022
Rootine is a health and wellness company that uses technology to provide personalized nutrition solutions. It begins by understanding an individual's unique nutritional needs through lab tests and wearable analytics, then offers tailored nutrient formulas and guidance. Users can track progress via their Rootine dashboard, with recommendations continually refined based on data and body changes.

Phytolon

Series A in 2022
Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.

Chinova Bioworks

Series A in 2022
Chinova Bioworks develops natural antimicrobial solutions based on a chitosan polymer derived from fungal-sourced technology, offering broad-spectrum protection to extend the shelf life of juices and other products. The company targets the beverage industry and broader markets, including foods, cosmetics, and personal care items, with a natural preservative designed to reduce spoilage and waste. Founded in 2016 and based in Fredericton, Canada.

Inne

Series A in 2022
Inne is a Berlin-based biotech startup that develops a hormone-based mini lab for women. It aims to make natural contraception convenient and accurate by tracking hormones via an app, helping women understand their fertility and overall health.

OK Capsule

Seed Round in 2022
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.

OK Capsule

Seed Round in 2021
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

Rootine

Seed Round in 2021
Rootine is a health and wellness company that uses technology to provide personalized nutrition solutions. It begins by understanding an individual's unique nutritional needs through lab tests and wearable analytics, then offers tailored nutrient formulas and guidance. Users can track progress via their Rootine dashboard, with recommendations continually refined based on data and body changes.

Prenexus Health

Series B in 2021
Prenexus Health, Inc. is a manufacturer of natural prebiotic ingredients, specializing in the scientific research, development, and production of components for functional foods, beverages, and dietary supplements. Founded in 2015 and headquartered in Gilbert, Arizona, the company emphasizes digestive health and wellness through its innovative offerings, including XOS95, a highly purified prebiotic ingredient derived from high-fiber sugarcane. Prenexus Health is recognized as a global leader in the prebiotic sector, underpinned by extensive scientific and clinical research that supports its products' efficacy in enhancing digestive and microbiome health. The company serves clients in the fast-moving consumer goods sector, providing them with high-quality functional ingredients to improve their products.

Inkbit

Series B in 2021
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of advanced 3D printers. The company has created a next-generation additive manufacturing platform that integrates machine vision and multi-material jetting technologies. By leveraging expertise from MIT-trained scientists and engineers, Inkbit aims to address the challenges of mass-market additive manufacturing. Its innovative approach enables rapid, on-demand production of polymer 3D printed parts, effectively bridging the gap between prototyping and full-scale manufacturing. This capability caters to the needs of industries requiring high precision and speed for complex, multi-material end-use products.

Leading Edge Equipment Technologies

Convertible Note in 2021
Founded in 2008, this company specializes in manufacturing equipment for solar panel production. Its core technology, the floating silicon method, enhances wafer efficiency, reduces manufacturing costs and emissions.

Brains Bioceutical

Series A in 2021
Brains Bioceutical specializes in the production of naturally-sourced active pharmaceutical ingredients (APIs) for various industries, including pharmaceuticals and nutraceuticals. Its product range includes CBD oil, capsules, balm, and spray, serving sectors such as health and wellness, skin care, beauty, and veterinary.

Meatable

Series A in 2021
Meatable is a Dutch food production company that specializes in creating cultured meat using stem cell technology. Founded in 2019, the company employs pluripotent stem cells to transform various types of cells into muscle or fat tissue, eliminating the need for animal slaughter. This process enables Meatable to produce sustainable, guilt-free meat without compromising taste and texture.

Deep Branch Biotechnology

Series A in 2021
Deep Branch Biotechnology Ltd., founded in 2018 and based in Nottingham, United Kingdom, specializes in carbon recycling services aimed at creating sustainable food ingredients. The company employs a proprietary gas fermentation platform that utilizes clean and renewable carbon and energy sources to produce bio-based products for the food and feed markets. By focusing on customer-driven research and development, Deep Branch rapidly delivers high-quality ingredients while collaborating with local providers to ensure sustainable input supplies and support local economies. Its approach includes integrating with carbon dioxide suppliers to deploy its technology efficiently, contributing to a reduction in carbon footprints by up to 60% compared to traditional alternatives. This innovative model allows Deep Branch to create locally-produced ingredients that require no arable land and minimal water, effectively addressing climate change and biodiversity loss while ensuring that consumers do not have to compromise on nutrition or quality.

Novum Medical

Venture Round in 2021
Novum Medical is a developer of innovative orthopedic implants, specializing in resorbable ortho-biomaterials designed for musculoskeletal surgery. The company focuses on creating products that utilize bioactive glass, which possesses porous, load-bearing, and osteoconductive properties. These advanced materials enhance the interface between the implant and bone, promoting a more natural healing process and improving overall performance. Novum Medical's technologies aim to enable surgeons to reconstruct bony anatomy effectively, addressing the clinical limitations associated with existing options in the market. The company's research and development efforts have broad applications within the musculoskeletal system.

Additive Manufacturing Technologies

Series A in 2021
AMT specializes in automated post-production technology for additive manufacturing. Its platform, PostPro, enhances cost efficiency, quality, safety, and throughput in the production of 3D printed parts.

Frontier Nutrition

Series B in 2021
Founded in 2017, Frontier Nutrition develops and manufactures packaged food products, focusing on pediatric nutrition research. Their products are localized for traditional diets, optimized for taste, nutrition, and price, aiming to provide affordable nutritious options to low-income families worldwide.

Leading Edge Equipment Technologies

Series A in 2020
Founded in 2008, this company specializes in manufacturing equipment for solar panel production. Its core technology, the floating silicon method, enhances wafer efficiency, reduces manufacturing costs and emissions.

NutriLeads

Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Phynova Group

Venture Round in 2020
Phynova Group is a British life science company that develops and commercialises plant-derived natural healthcare products and drug candidates. Founded in 2002 and headquartered in Long Hanborough, United Kingdom, with research activities in Beijing, it focuses on products based on traditional Chinese medicine and other botanical sources for global health needs. Its portfolio includes pharmaceutical candidates in gastroenterology, anti-infective, and metabolic disorders, such as Melokinex and PYN17 in Phase II trials, Phytobacx for MRSA and acne, PYN22 for obesity and nonalcoholic fatty liver disease, and PYN8 in preclinical stage for type-2 diabetes. The company also markets functional ingredients and OTC products, including PhynoRadiance, FatigFix, Relivergen, and IminoNorm, and develops TCM-derived OTCs for arthritis, cold and flu. It serves global healthcare and consumer goods markets.

Panaceutics Nutrition

Series A in 2020
Panaceutics Nutrition is a company that specializes in the formulation, manufacturing, and distribution of customized nutritional products. Founded in 2018 by Edison Hudson and Staton Noel, it is based in Ringgold, Virginia. The company employs proprietary robotic technology to create individually tailored smoothies and nutritional supplements, which can be based on genetic and medical evaluations, as well as personal preferences. Panaceutics Nutrition focuses on mass customization, offering solutions that combine various nutritional supplements into convenient, easy-to-consume forms such as flavored gels and purees. By serving healthcare systems, pharmaceutical companies, and nutritional product manufacturers, the company aims to provide accessible and personalized nutrition to meet diverse consumer needs.

Inkbit

Venture Round in 2019
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of advanced 3D printers. The company has created a next-generation additive manufacturing platform that integrates machine vision and multi-material jetting technologies. By leveraging expertise from MIT-trained scientists and engineers, Inkbit aims to address the challenges of mass-market additive manufacturing. Its innovative approach enables rapid, on-demand production of polymer 3D printed parts, effectively bridging the gap between prototyping and full-scale manufacturing. This capability caters to the needs of industries requiring high precision and speed for complex, multi-material end-use products.

Voxel8

Series B in 2019
Voxel8 Inc. is a Somerville, Massachusetts-based company that specializes in designing and manufacturing advanced electronic devices and digital 3D printing technologies. Incorporated in 2013, Voxel8 offers desktop 3D printers that utilize thermoplastics and UV resins, enabling the rapid fabrication of customizable electronic devices. The company's proprietary Project Wire software facilitates the design of 3D printable electronics, streamlining the production process. Voxel8's unique technology is particularly applicable in textile applications, allowing for the zonal tuning of mechanical properties and the enhancement of aesthetic features in products such as footwear, apparel, and medical devices. This additive manufacturing approach minimizes waste and supports sustainability through the use of bio-based materials. Voxel8's innovations enable customization of individual prints, enhancing performance characteristics like abrasion resistance, cushioning, and grip, while also incorporating full-color graphics and 3D embellishments. The technology was developed in collaboration with Professor Jennifer Lewis at Harvard University, positioning Voxel8 at the forefront of digital manufacturing in the textile and electronic sectors.

Additive Manufacturing Technologies

Series A in 2019
AMT specializes in automated post-production technology for additive manufacturing. Its platform, PostPro, enhances cost efficiency, quality, safety, and throughput in the production of 3D printed parts.

Chinova Bioworks

Seed Round in 2019
Chinova Bioworks develops natural antimicrobial solutions based on a chitosan polymer derived from fungal-sourced technology, offering broad-spectrum protection to extend the shelf life of juices and other products. The company targets the beverage industry and broader markets, including foods, cosmetics, and personal care items, with a natural preservative designed to reduce spoilage and waste. Founded in 2016 and based in Fredericton, Canada.

ZeaVision

Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.

Panaceutics Nutrition

Venture Round in 2019
Panaceutics Nutrition is a company that specializes in the formulation, manufacturing, and distribution of customized nutritional products. Founded in 2018 by Edison Hudson and Staton Noel, it is based in Ringgold, Virginia. The company employs proprietary robotic technology to create individually tailored smoothies and nutritional supplements, which can be based on genetic and medical evaluations, as well as personal preferences. Panaceutics Nutrition focuses on mass customization, offering solutions that combine various nutritional supplements into convenient, easy-to-consume forms such as flavored gels and purees. By serving healthcare systems, pharmaceutical companies, and nutritional product manufacturers, the company aims to provide accessible and personalized nutrition to meet diverse consumer needs.

Hyalex Orthopaedics

Series A in 2019
Hyalex Orthopaedics, Inc. is a medical device company based in Lexington, Massachusetts, focused on developing and commercializing innovative products utilizing its proprietary HYALEX technology. This synthetic polymer is specifically designed to mimic the properties of natural cartilage, offering a unique advantage in maintaining low friction and wear under the high loads typically encountered in human joints. The company's goal is to provide solutions for diseased and damaged joints by enabling the replacement of arthritic cartilage while preserving healthy bone. Currently, Hyalex Orthopaedics' products remain in the development stage and have yet to receive regulatory approval for human use.

Adaptive3D

Series A in 2019
Adaptive3D is a leading supplier of premium additive manufacturing polymer resins focused on enabling high-volume production through optimized materials. The company specializes in a range of offerings, including rubber-like 3D printable materials, damping materials, and low-cure stress photopolymers. By leveraging pioneering technologies, Adaptive3D provides high-quality polymer resins and specialty polymers that empower clients to create functional end-use products and prototypes with precise internal geometries. Their innovative solutions facilitate the production of differentiated products and enhance part performance, positioning Adaptive3D as a key player in the additive manufacturing industry.

RayCatch

Series B in 2018
RayCatch develops an AI-driven SaaS platform that optimizes solar asset management. It analyzes existing data to identify issues like underperforming panels, disconnected cables, and maintenance needs, enabling automated, on-demand management. This maximizes performance, reduces operational costs, and accelerates solar energy adoption globally.

Miach Orthopaedics

Series A in 2018
Miach Orthopaedics is a medical device company based in Westborough, Massachusetts, specializing in the development of bio-engineered surgical implants aimed at promoting new tissue growth and aiding in connective tissue repair. Founded in 2016, the company focuses on its innovative Bridge-Enhanced ACL Repair technology, which serves as an alternative to traditional anterior cruciate ligament (ACL) reconstruction. This technology provides surgeons with a method to restore the normal anatomy and function of the knee for patients who have experienced ACL injuries, offering a promising option for recovery and rehabilitation.

Novum Medical

Series C in 2018
Novum Medical is a developer of innovative orthopedic implants, specializing in resorbable ortho-biomaterials designed for musculoskeletal surgery. The company focuses on creating products that utilize bioactive glass, which possesses porous, load-bearing, and osteoconductive properties. These advanced materials enhance the interface between the implant and bone, promoting a more natural healing process and improving overall performance. Novum Medical's technologies aim to enable surgeons to reconstruct bony anatomy effectively, addressing the clinical limitations associated with existing options in the market. The company's research and development efforts have broad applications within the musculoskeletal system.

Chinova Bioworks

Seed Round in 2018
Chinova Bioworks develops natural antimicrobial solutions based on a chitosan polymer derived from fungal-sourced technology, offering broad-spectrum protection to extend the shelf life of juices and other products. The company targets the beverage industry and broader markets, including foods, cosmetics, and personal care items, with a natural preservative designed to reduce spoilage and waste. Founded in 2016 and based in Fredericton, Canada.

Chromatic 3D Materials

Series A in 2018
Chromatic 3D Materials specializes in developing advanced materials for additive manufacturing. They focus on creating durable elastomer materials for 3D printing, enabling the production of flexible and resilient parts suitable for finished manufactured goods.

Tespo

Series A in 2018
Tespo manufactures a liquid vitamin dispenser helping individuals with health goals. The company's system provides all the storage, convenience, and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives, or unnecessary ingredients.

Leading Edge Equipment Technologies

Seed Round in 2017
Founded in 2008, this company specializes in manufacturing equipment for solar panel production. Its core technology, the floating silicon method, enhances wafer efficiency, reduces manufacturing costs and emissions.

ATRO Medical

Series A in 2017
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.

NutriLeads

Series A in 2017
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

QD Solar

Series A in 2017
QD Solar Inc., founded in 2014 and based in Toronto, Canada, is a company that develops advanced photovoltaic cells using colloidal quantum dot technology. The company's innovative approach combines efficient silicon solar cells with infrared solar cells in a hybrid architecture to capture more of the solar spectrum than traditional silicon cells alone. This technology aims to enhance the performance of solar cells, making them more cost-effective and efficient. QD Solar was spun off from the University of Toronto and focuses on creating new nanomaterial semiconductors to promote sustainable development and increase the use of renewable energy sources.

WattGlass

Series A in 2017
WattGlass LLC, established in 2014 and headquartered in Fayetteville, Arkansas, specializes in developing water-based anti-reflective coatings for glass and other transparent materials. The company's proprietary nanoparticle coating technology significantly reduces reflection, glare, and fogging, catering to diverse applications such as automotive, consumer goods, architectural glass, and solar photovoltaic industries. WattGlass' innovative solutions aim to replace hazardous materials commonly used in these sectors, offering an environmentally friendly alternative with improved durability and shelf life.

Essential Medical

Series B in 2016
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in the development and marketing of femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has developed two key devices, including MANTA, which is designed to close large bore punctures ranging from 10 to 24 French following various vascular access procedures such as transcatheter aortic valve replacement, abdominal aortic aneurysm repair, and balloon aortic valvuloplasty. These closures are critical in the rapidly growing field of interventional cardiology, enabling physicians to address the need for efficient and complication-free closure solutions. As of October 2018, Essential Medical operates as a subsidiary of Teleflex Incorporated.

Blue Prairie

Series A in 2016
Blue Prairie Brands LLC, based in Charlottesville, Virginia, specializes in the manufacture of inulin, a prebiotic ingredient known for its health benefits. The company produces soluble, indigestible fibers that enhance the nutritional content of various food products, beverages, and dietary supplements. Their flagship product is a gluten-free, non-GMO form of inulin, which supports digestive health when combined with probiotics. Additionally, Blue Prairie's innovative approach to production offers farmers a profitable rotation crop that aligns with their existing agricultural practices. By focusing on functional foods and dietary fiber, Blue Prairie Brands aims to improve the nutritional value of products in the market while promoting a healthy gut environment.

Arecor

Venture Round in 2016
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.

NOMADD Desert Solar Solutions

Series A in 2016
NOMADD Desert Solar Solutions specializes in innovative cleaning solutions for solar panels, particularly in desert environments. Headquartered in Saudi Arabia, the company has developed the NOMADD, a no-water mechanical automated dusting device designed to effectively clean solar panels in challenging, dusty conditions. This advanced system allows for the maintenance of solar installations in arid climates without the use of water, thereby preventing damage to the panels while ensuring optimal performance. The NOMADD device was initially developed at the King Abdullah University for Science and Technology, reflecting a strong foundation in research and innovation. Through its unique approach, NOMADD addresses the specific cleaning challenges posed by desert environments, making it a vital player in the solar energy sector.

NutriLeads

Seed Round in 2015
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Natreon

Venture Round in 2015
Natreon, Inc. is a New Jersey-based company specializing in the development and marketing of Ayurvedic products. Founded in 1998, it operates a state-of-the-art research and development facility in Kolkata, India. Natreon focuses on creating dietary supplements derived from traditional Ayurvedic ingredients, with products such as CAPROS, an all-natural antioxidant for cardiovascular health; SENSORIL, an Ashwagandha formulation aimed at reducing stress and enhancing cognition; AYUFLEX, designed for joint health; and PRIMAVIE, a mitochondrial energy booster. The company emphasizes rigorous research and has established multiple clinical and safety studies to support its product efficacy. Natreon holds patents for its offerings in the United States and internationally, reinforcing its commitment to high standards and innovation in the wellness sector.

NovoPolymers

Venture Round in 2015
NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.

Interface Biologics

Series B in 2015
Interface Biologics develops biomedical polymer technology to enhance the safety and efficacy of medical devices. Its patented technologies include anti-thrombogenic additives for blood-contacting devices and combination drug delivery systems. The company has licensing agreements with AngioDynamics and Fresenius Medical Care, and a joint venture with Qualimed. Headquartered in Toronto, Canada, Interface Biologics was founded in 2001.

EyePromise

Venture Round in 2014
EyePromise specializes in manufacturing dietary supplements rich in zeaxanthin, a nutrient crucial for maintaining eye health. Their products aim to reduce the risk of age-related macular degeneration and improve overall visual performance.

Verdezyne

Venture Round in 2014
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

Isobionics

Venture Round in 2014
Isobionics is a biotechnology company specializing in the production of natural aroma ingredients for various markets, including food, beverage, flavor, and fragrance. Utilizing a proprietary fermentation process, Isobionics focuses on isoprenoid-based products, such as nootkatone and valencene, which are essential for creating high-quality flavors and fragrances. This innovative approach ensures that the ingredients are free from pesticides and seasonal variability, resulting in products that are both purer and more cost-effective. By delivering superior sensory experiences, Isobionics aims to meet the evolving needs of its customers across the food, beverage, oral care, and personal care industries.

ChromaDex

Post in 2013
ChromaDex is a global nutraceutical company that discovers, acquires, develops, and commercializes patented ingredients for dietary supplements, food, beverage, skin care, and pharmaceutical markets. Its flagship product, Niagen (nicotinamide riboside), enhances NAD levels for healthy aging.

Arecor

Venture Round in 2013
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.

Segetis

Series C in 2012
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, specializing in the development, production, and commercialization of renewable polymers. Founded in 2006, Segetis focuses on a platform of binary monomers derived from renewable feedstocks, including non-food agricultural and forestry materials. The company's innovative technology supports the production of a range of industrial bioproducts such as bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, catering to specialty chemical applications. Segetis's chemistries create opportunities for product enablement and synergies across various industries, including those involved in the processing of starch, sugar crops, wood, cellulose, and paper pulp, as well as the chemical processing of vegetable oils and the manufacturing of biodiesel and linear alpha-olefins.

Xolve

Funding Round in 2012
Xolve Inc., established in 2008 and headquartered in Middleton, Wisconsin, specializes in the production and supply of graphene for industrial applications. The company offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene, which enhance properties such as modulus, electrical conductivity, thermal conductivity, barrier properties, and flame retardancy in various plastics used across automotive, aerospace, electronics, and other sectors. Xolve's unique processing technology enables effective, simple, room-temperature production of graphene composites. As of 2016, the company operates as a subsidiary of Reliance Industries Limited.

Regentis Biomaterials

Series C in 2012
Regentis Biomaterials Ltd. is a company specializing in tissue repair, particularly in the development and commercialization of biodegradable hydrogels for repairing damaged cartilage tissue. Founded in 2004 and based in Or-Akiva, Israel, with an additional office in Princeton, New Jersey, the company’s core technology includes Gelrin, a hydrogel matrix composed of polyethylene glycol diacrylate and denatured fibrinogen. This innovative platform merges the stability of synthetic materials with the bio-functionality of natural substances, catering to various clinical applications. Regentis's flagship product, GelrinC, is designed for treating articular cartilage lesions and is currently undergoing clinical trials. The company’s focus is on orthopedic treatments, aiming to restore health and improve the quality of life for patients suffering from cartilage damage and related conditions.

Verdezyne

Venture Round in 2011
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

CellMade

Funding Round in 2010
CellMade SAS is a biopharmaceutical company based in Chappes, France, with additional facilities in Marseille and Ruffieux. Founded in 2007, the company specializes in developing and supplying a range of cell biology products, including human-origin primary cells and various types of specialized cells such as blood cells, endothelial cells, and pancreatic cells. CellMade also offers laboratory services that encompass biobanking, cell-based assays, cytometry, and mass spectrometry. The company invests in its research and development initiatives through its CellInsight platform, which focuses on identifying targets and biomarkers associated with inflammatory pathologies. By providing customized cell isolation and co-culture models, CellMade aims to advance the field of cell biology and support various research applications.

Segetis

Series B in 2010
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, specializing in the development, production, and commercialization of renewable polymers. Founded in 2006, Segetis focuses on a platform of binary monomers derived from renewable feedstocks, including non-food agricultural and forestry materials. The company's innovative technology supports the production of a range of industrial bioproducts such as bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, catering to specialty chemical applications. Segetis's chemistries create opportunities for product enablement and synergies across various industries, including those involved in the processing of starch, sugar crops, wood, cellulose, and paper pulp, as well as the chemical processing of vegetable oils and the manufacturing of biodiesel and linear alpha-olefins.

Novomer

Series B in 2009
Novomer is a materials company based in Waltham, Massachusetts, founded in 2004. The company specializes in developing high-performance green plastics, polymers, and other chemicals using proprietary catalytic technology. This technology enables the cost-effective transformation of carbon dioxide and other renewable materials into various industrial products. By combining traditional chemical feedstocks with carbon dioxide or carbon monoxide, Novomer aims to create sustainable chemicals and materials for diverse applications, contributing to efforts in mitigating global warming and climate change.

Viocare

Venture Round in 2009
Viocare Inc., a privately-held company, specializes in developing innovative web and mobile solutions that combine advanced nutrition science and behavior change strategies. Its cloud-based platform offers assessment tools for academic research and clinical use, analyzing dietary behaviors to generate personalized lifestyle plans. Viocare's software facilitates remote or face-to-face nutritional counseling, driving sustainable behavior changes and enabling healthcare professionals to integrate affordable, effective nutritional care into their patient services.

Provexis

Post in 2008
Provexis plc is a UK-based company that specializes in the development, licensing, and marketing of functional foods, medical foods, and dietary supplements on a global scale. Founded in 1999 and headquartered in Reading, Provexis is known for its flagship product, Fruitflow, a tomato extract that helps reduce the risk of abnormal blood clotting associated with cardiovascular diseases, including heart attacks and strokes. Fruitflow is available in syrup and powder forms, which can be incorporated into various food, beverage, and dietary supplement products. Additionally, Provexis offers Fruitflow + Omega-3, a capsule supplement that promotes healthy blood flow and supports normal heart function. The company has a collaboration agreement with By-Health Co., Ltd. and distributes its products through retail outlets and online platforms.

Ganeden Biotech

Venture Round in 2007
Ganeden, Inc. is a biotechnology company based in Mayfield Heights, Ohio, that specializes in the manufacture and supply of probiotics and probiotic bacteria. Founded in 1997, the company focuses on developing advanced strains of probiotics that address limitations associated with traditional strains. Ganeden licenses its probiotic technology for use in a variety of applications, including functional food and beverages, dietary supplements, and personal care products. Key offerings include GanedenBacillus coagulans for food and beverage applications, Bonicel for anti-aging cosmetics, and Staimune, an immune health solution. The company has also established a strategic alliance with Sensus America. With a commitment to improving quality of life, Ganeden has successfully introduced a range of consumer products, selling nearly 200 million doses across over 40,000 retail outlets since its product launch in 2003. As of 2017, Ganeden operates as a subsidiary of Kerry Group plc.

Food Quality Sensor International

Series B in 2007
Food Quality Sensor International, Inc. is a sensor technology company based in Lexington, Massachusetts, that specializes in real-time and interactive devices for measuring food freshness. Founded in 2004, the company offers innovative products such as SensorQ, which assesses the freshness of meat and poultry within their packaging, and SensorfreshQ, a handheld electronic nose designed to detect spoilage in these products. Its solutions cater to various sectors including food processing, grocery distribution, food service, regulatory bodies, defense, and consumer retail markets, aiming to enhance food safety and quality across the supply chain.

Harland Medical Systems

Private Equity Round in 2007
Founded in Minnesota in 2003, Harland Medical Systems specializes in enhancing the functionality of healthcare products through integrated surface solutions. The company offers UV-curable antimicrobial coatings and adhesion primers to improve the performance and safety of medical devices across various clinical markets.

Micromuscle

Venture Round in 2006
Micromuscle AB, established in 2000, specializes in the development of innovative biomedical products utilizing its proprietary electroactive polymer technology known as MICROMUSCLE. This technology enables electroactive polymers to expand and contract in response to an electric potential, making it particularly suitable for various vascular applications. By focusing on the unique properties of these materials, Micromuscle aims to advance the field of biomedical engineering through the creation of effective and efficient solutions.

IntegraGen

Venture Round in 2006
IntegraGen is a French biotechnology company located in the Genopole life science park in Evry, near Paris. The company specializes in the development of genetic biomarkers and leverages its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotechnology firms, and research organizations. IntegraGen offers a range of services, including clinical research, bioinformatics, and bioanalysis, as well as solutions for agrigenomics and microbiologic research. With its unique intellectual property and access to extensive sample libraries, IntegraGen aims to advance the understanding and treatment of central nervous system and metabolic diseases.

Sciona

Series C in 2006
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

ORYXE Energy International

Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.

Sciona

Series B in 2004
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Morphotek

Series C in 2004
Morphotek, established in 2000, is a prominent life science company specializing in developing novel biological products to combat cancer, inflammation, and infectious diseases. The company's core technology, morphogenics, was co-invented by its current President and CEO, Dr. Nicholas Nicolaides, during his postgraduate research at Johns Hopkins Medical School. Morphotek focuses on discovering and developing monoclonal antibodies (mAbs) using this proprietary technology to treat various conditions such as ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The company conducts independent research and clinical development programs for its drug candidates.

Optiva

Series C in 2003
Optiva develops and manufactures nanomaterials for use in optical, electro-optical, and semiconductor applications.

Sciona

Series A in 2002
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.